Whole body PET(CT) with FDG for treatment monitoring of patients with bone metastatic breast cancer

被引：0
|
作者：
Huyge, V.
Flamen, P.
Bergmann, P.
Ameye, L.
Vanderlinden, B.
Garcia, C.
Alexiou, J.
Lemort, M.
Awada, A.
Body, J.
机构：
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] Hop Brugmann, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1088
引用
收藏
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET/CT for monitoring treatment response in bone-dominant metastatic breast cancer patients.
    Portilla Merino, P.
    Escabias del Pozo, C.
    Abadi Sedraoui, Y.
    Lopez Llobet, E.
    Giraldo Gonzalez, L.
    Rizkallal Monzon, S.
    Monachello Araujo, D.
    Lancha Hernandez, C.
    Rodado Marina, S.
    Coronado Poggio, M.
    Cordero Garcia, J.
    Dominguez Gadea, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S481 - S481
  • [2] Comparison of the diagnostic value of whole-body DWI, 18F-FDG PET/CT and whole-body CT in metastatic breast cancer
    Gelezhe, Pavel
    Morozov, Sergey
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [3] Monitoring Therapy of Bone-dominant Metastatic Breast Cancer with 18F-FDG PET/CT
    Hascsi, Z.
    Nagy, E.
    Fedinecz, N.
    Varga, J.
    Toth, J.
    Mezei, K.
    Garai, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S216 - S217
  • [4] Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
    De Giorgi, U.
    Valero, V.
    Rohren, E.
    Mego, M.
    Doyle, G. V.
    Miller, M. C.
    Ueno, N. T.
    Handy, B. C.
    Reuben, J. M.
    Macapinlac, H. A.
    Hortobagyi, G. N.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (01) : 33 - 39
  • [5] CIRCULATING TUMOR CELLS AND BONE METASTASES AS DETECTED BY FDG-PET/CT IN PATIENTS WITH METASTATIC BREAST CANCER
    De Giorgi, U.
    Valero, V.
    Rohren, E.
    Doyle, G. V.
    Ueno, N. T.
    Handy, B. C.
    Reuben, J. M.
    Cristofanilli, M.
    Macapinlac, H. A.
    Hortobagyi, G. N.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 56 - 57
  • [6] Necessity of Whole Body Bone Scintigraphy In Patients With Lung Or Breast Cancer Who Underwent Whole Body 18F FDG-PET/CT For Initial Staging
    Gortan, F.
    Doner, Z. Kaya
    Topuz, O. Vural
    Arslan, E.
    Halac, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S510 - S511
  • [7] Sarcoidosis Mimicking Metastatic Breast Cancer on FDG PET/CT
    Zivin, Sean
    David, Odile
    Lu, Yang
    [J]. INTERNAL MEDICINE, 2014, 53 (21) : 2555 - 2556
  • [8] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Christopher C. Riedl
    Katja Pinker
    Gary A. Ulaner
    Leonard T. Ong
    Pascal Baltzer
    Maxine S. Jochelson
    Heather L. McArthur
    Mithat Gönen
    Maura Dickler
    Wolfgang A. Weber
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1428 - 1437
  • [9] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Riedl, Christopher C.
    Pinker, Katja
    Ulaner, Gary A.
    Ong, Leonard T.
    Baltzer, Pascal
    Jochelson, Maxine S.
    McArthur, Heather L.
    Gonen, Mithat
    Dickler, Maura
    Weber, Wolfgang A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1428 - 1437
  • [10] FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Dalus, Katharina
    Rendl, Gundula
    Rettenbacher, Lukas
    Pirich, Christian
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) : 1992 - 1993
12345